Xcout IntelPropanc Biopharma, Inc.
Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal malignancies. The company's leading therapeutic candidate, PRP, is a unique formulation currently in the preclinical stage of development. This product is designed to enhance the effectiveness of multiple enzymes that work together to combat cancer. Propanc Biopharma is also engaged in a collaborative research effort with the University of Jaén, initiating the POP1 joint drug discovery program. Founded in 2007, the entity was originally known as Propanc Health Group Corporation before officially changing its name to Propanc Biopharma, Inc. in April 2017. The company's headquarters are located in Camberwell, Australia.
Subscribe to see Propanc Biopharma, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Propanc Biopharma, Inc. at a glance
Propanc Biopharma, Inc. is a biotech company headquartered in Camberwell, Australia. It is publicly listed (PPCB) with a market capitalisation of $2.6M. Xcout tracks 8 named people at Propanc Biopharma, Inc., including James Nathanielsz (Chief Executive Officer & Executive Chairman).
Propanc Biopharma, Inc. leadership
- James NathanielszChief Executive Officer & Executive Chairman
- Jeannine ZimmermanChief Financial Officer
- Dr. Ralf BrandtResearch & Development Director
- Carlo CampicianoIndependent Director
- James Andrew NathanielszDirector
- Josef ZelingerDirector
2 more named people on record for Propanc Biopharma, Inc., with roles, board committees and tenure — see the full roster →
Get Propanc Biopharma, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Propanc Biopharma, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access